The Jerome Lipper Multiple Myeloma Center provides comprehensive care to patients with multiple myeloma, including promising new therapies through clinical trials rooted in an approach that brings laboratory discoveries quickly to the clinical setting. We conduct an active program of basic and clinical research aimed at improving the outcomes of multiple myeloma.
Our Treatment Approach
We provide a comprehensive range of services for patients, including:
- Consultation and confirmation of diagnosis
- Development of a personalized treatment plan offering the latest therapies (combination chemotherapy, novel biologically based therapies, CAR T-cell therapy, radiation therapy)
- Access to clinical trials involving novel therapies (Phase I/II/III studies)
- Comprehensive bone marrow/stem cell transplantation services
- Support services for patients and the families
- Access to complementary therapies through the Leonard P. Zakim Center for Integrated Therapies and Healthy Living
- Follow-up care, including collaboration with your local (referring) physician
Early Detection and Prevention of Multiple Myeloma
Our Center for Early Detection and Interception of Blood Cancers (formerly the Center for Prevention of Progression) cares for patients diagnosed with – or at high risk for – precursor conditions of multiple myeloma such as MGUS and smoldering myeloma. The clinic works with patients to manage their risk of disease progression and offers clinical trials of early intervention therapies to prevent disease progression.
570x367.jpg?crop=yes&k=c&w=392&h=275&itok=rCR39gHS)
